Research and Markets (http://www.researchandmarkets.com/research/5ptlsd/retinitis) has announced the addition of the "Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2013" report to their offering.

Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2013 provides data on the Retinitis Pigmentosa (Retinitis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinitis Pigmentosa (Retinitis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinitis Pigmentosa (Retinitis).

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies Participating in Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials

  • QLT Inc.
  • R-Tech Ueno, Ltd.
  • Neurotech Pharmaceuticals, Inc.
  • Oxford BioMedica plc
  • Johnson & Johnson
  • Isis Pharmaceuticals, Inc.
  • DNAVEC Corporation
  • Daewoong Pharmaceutical Co., Ltd.
  • BioDiem Ltd
  • Allergan, Inc.

Clinical Trial Overview of Top Institutes / Government

  • National Eye Institute
  • The Sheba Medical Center
  • Kyushu University
  • National Center for Research Resources
  • Southwest Hospital, China
  • University of Sao Paulo
  • Columbia University
  • Third Military Medical University
  • Tehran University of Medical Sciences
  • Chiba University Hospital

For more information visit http://www.researchandmarkets.com/research/5ptlsd/retinitis

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals